MetaCap

K2 Capital Acquisition (KTWO) vs OraSure Technologies (OSUR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

OraSure Technologies is the larger company by market cap ($238.9 million vs $203.0 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

KTWO+2.53%OSUR+17.21%
+49%+20%-8%
Feb 26, 20261 yearNov 19, 2026
KTWO+2.64%OSUR+9.84%
+44%+18%-9%
Feb 23, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

KTWO versus OSUR key metrics
MetricKTWOOSUR
Share price$10.13$3.46
Market cap$203.02M$238.90M
1-day change0.00%-4.16%
YTD return—+42.98%
1-year return—+52.42%
5-year return—-63.69%
EPS (TTM)—$-0.69
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$115.02M
Revenue growth (YoY)—-38.10%
Net income (latest FY)—$-68.73M
Gross margin—41.90%
Operating margin—-62.57%
Net margin—-59.76%
52-week high$10.13$4.58
52-week low$0.00$2.28
Distance from 52-week high0.00%-24.45%
Analyst consensus—buy
Avg. price target upside—+58.96%
Average volume17.07K571.50K
Shares outstanding14.13M69.05M
Employees—500
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About K2 Capital Acquisition

KTWO stock →

K2 Capital Acquisition Corporation does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in the physical AI or energy transition sectors.

Health Care · Medical/Dental Instruments

About OraSure Technologies

OSUR stock →

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.

Health Care · Medical/Dental Instruments · 500 employees

KTWO vs OSUR FAQ

Which is bigger, K2 Capital Acquisition or OraSure Technologies?

OraSure Technologies (OSUR) is larger, with a market capitalization of $238.90M compared with $203.02M for K2 Capital Acquisition (KTWO).

Are K2 Capital Acquisition and OraSure Technologies in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons